Compared to qPCR, digital PCR achieves not only higher sensitivity but also absolute quantification when detecting gene mutations.

Turtle Technology focuses on the innovation and application of digital PCR platforms, with a core team possessing 20 years of technical expertise and extensive experience in the development, validation, and production of digital PCR test kits. We provide support to clients from various fields, including life science projects, clinical diagnostics, and drug development, by detecting target nucleic acids in blood or other biological samples. Our areas of interest cover various specific sequences, from protein-coding regions to diverse biological sources, such as tumors, microorganisms, embryos, iPS cells, and environmental DNA.

In addition, Turtle Technology's groundbreaking Exponential Ultra-Multiplex Technology allows the simultaneous detection of far more targets than the number of fluorescence channels, greatly expanding the application scope of PCR. It can even partially replace expensive NGS for certain tests, achieving the effect of "qPCR-PLUS/NGS-SHARP" providing clients with more possibilities and driving industry development.

Turtle Technology has already developed a series of test kits, but more importantly, we support partners in co-development and customization based on our platform. Partners who have previously developed qPCR assay kits can easily adapt to our dPCR systems with minimal optimization, as the platform is backward compatible, enabling a swift and straightforward transition. We will always strive to help our partners move from traditional qPCR to the new era of digital PCR!

Turtle Tech's Proprietary Digital PCR Detection Kits - Product Catalog